Evaluation of Four-Factor Prothrombin Complex Concentrate Dosing Strategies for the Reversal of Bleeding Associated with Apixaban or Rivaroxaban

Publication Date

2023

Presented At:

ASHP Midyear Meeting. Anaheim, California

Content Type

Poster

This document is currently not available here.

Share

COinS